IDH1 and oligodendroglioma: The discovery of mutations in the IDH1 and IDH2 genes in astrocytic and oligodendroglial tumours has led to a biomarker-driven classification, forming an integrated diagnosis composed of the histological appearance and the molecular profile [1].